Julia Kern
study nurse
Medizinische Onkologie und Hämatologie · Dept. I
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-resistant Prostate Cancer
Nov 30, 2022Diese Studie wird durchgeführt, um mehr über AMG 509 als Monotherapie (Einzelmedikament) und AMG 509 in Kombination mit Abirateron oder Enzalutamid oder Pemb-rolizumab bei Patienten mit metastasiertem kastrationsre-sistentem Prostatakrebs (mCRPC) zu...
Clinical Studies - Nov 30, 2022 - Dec 31, 2026
Ongoing
Project leader: Fischer Stefanie
Members: Kern Julia, Quinter Janine
ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib
Apr 14, 2021TRK fusion cancer is rare but presents as a variety of solid tumors. Larotrectinib is a highly selective TRK inhibitor that, in a pooled analysis of patients in phase 1/2 clinical trials, demonstrated an effective and sustained response in the ma...
Clinical Studies - Apr 14, 2021 - Dec 31, 2025
Completed
Project leader: Jörger Markus
Members: Kern Julia, Quinter Janine